Skip to main content
. 2021 Nov 27;21:566. doi: 10.1186/s12872-021-02379-7

Table 1.

Clinical characteristics of the studied groups

Variables CAD patients
N = 66
NCAD patients
(Control group)
N = 16
P value
Age, years 62 (38–78) 64 (29–75)  0.727
Age of CAD, years 53 (37–73)
Male/female 49/17 8/8 > 0.05
BMI, kg/m2 27.9 (21.1–41) 23.9 (20.9–32.9) 0.029
Waist circumference, cm Males Males
98.5 (81–125) 84 (69–104) 0.001
Females Females
91 (79–113) 92 (58–103) 0.888
Waist-to-hip ratio Males: 0.96 ± 0.04 Males: 0.89 ± 0.04 0.024
Females: 0.82 ± 0.06 Females: 0.83 ± 0.11 0.931
EAT thickness, mm 6.49 ± 2.52 5.33 ± 1.93 0.106
Smoking
Never smoked 29 (44%) 14 (88%) 0.003
Ex-smokers 16 (24%) 1 (6%) 0.100
Smoking during the time of the study 12 (18%) 0 (0%) 0.060
Smoking status is unknown 9 (14%) 1 (6%)
Features of the diagnosis:
Patients with one-vessel coronary artery disease, N (%) 7 (10.1%)
Patients with two-vessel coronary artery disease, N (%) 16 (23.2%)
Patients with three-vessel coronary artery disease, N (%) 46 (66.7%)
Patients with CAD and established concomitant carotid artery disease or peripheral artery disease, N (%) 8 (12%)
Biochemical parameters
Triglyceride, mmol/L 1.47 (0.35–5.09) 1.07 (0.40–3.82) 0.042
Total cholesterol, mmol/L 4.85 ± 1.47 4.57 ± 1.02 0.592
HDL-cholesterol, mmol/L 1.21 (0.70–2.35) 1.20 (0.50–1.82) 0.369
LDL-cholesterol, mmol/L 2.59 ± 1.34 2.84 ± 0.53 0.339
Fasting glucose, mmol/L 5.55 (4.50–8.80) 5.25 (4.30–8.70) 0.083